Health Care/Hospital
KGC Launches Premium Ingredient Brand "G1899," for the Global B2B Health Ingredient Market
* KGC, a Global Health Leader, Expands into the B2B Ingredient Sector with Its Standardized Premium Brand "G1899" * Showcases "G1899" at the World's Largest Ingredient Exhibition, SSG 2025, Highlighting the Excellence of Red Ginseng * Demonstrates KGC's Quality Management Systems and Advanc...
2025-11-06 21:00
1576
Uniting Global Minds to Shape the Future of Healthcare -- The 3rd CREATE Symposium Opens in Hong Kong
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- In the era of artificial intelligence, the rapid advancements in AI and robotics are revolutionizing healthcare — reshaping diagnosis, treatment, and health management. How to deeply integrate these cutting-edge technologies into clinical practice, and tran...
2025-11-06 18:06
1925
Millennium Technology Prize opens its nomination period for innovations for a better life
HELSINKI, Nov. 6, 2025 /PRNewswire/ -- The world's leading innovation award, Millennium Technology Prize, will be awarded again inMay 2027. The eligibility criteria of the prize have been expanded to even more future-oriented innovations that improve the well-being of humankind and the planet and...
2025-11-06 16:15
1164
Leading Fertility Specialist Associate Professor Gavin Sacks joins Genea
SYDNEY, Nov. 6, 2025 /PRNewswire/ -- Genea Fertility, Australia's pioneering fertility network, is pleased to announce the appointment of internationally renowned fertility specialist, Associate ProfessorGavin Sacks, to its medical leadership team, continuing the organisation's 40-year tradition ...
2025-11-06 16:09
1320
KT&G sees record quarterly revenue and operating profit in Q3, raises guidance based on double-digit growth
* Quarterly global cigarette revenue surpasses KRW 500 billion for the first time; cigarette& NGP performs solidly hand-in-hand * Acquires ASF jointly with Altria, modern product's global expansion to gain momentum SEOUL, South Korea, Nov. 6, 2025 /PRNewswire/ -- KT&G (KRX: 033780) presented ...
2025-11-06 15:49
2704
International Symposium on Myofunctional Therapy Concludes Successfully in Shanghai, Strengthening Global Collaboration in Functional Orthodontics
SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- The International Symposium on Myofunctional Therapy in Multidisciplinary Collaboration, hosted by the Chinese Association of Orofacial Myology (CHAOM) and supported by Smartee Denti-Technology, concluded successfully inShanghai. The event brought together ...
2025-11-06 15:35
1581
Fosun Marks Eighth Year at CIIE, Guo Guangchang Calls for More Cutting-Edge Innovation
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- On 5 November 2025, the 8th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center (Shanghai). As a "full-attendance" exhibitor for eight consecutive years, Fosun, together with its overseas member companies and glob...
2025-11-06 15:19
3032
MediTrust Health Shares Insights at Hong Kong Fintech Week: AI Pragmatically Reshaping Cross-Border Healthcare Payments in the Greater Bay Area
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- MediTrust Health, the largest innovative healthcare payor platform inChina, delivered key insights recently at the HealthTech Forum of "Hong Kong FinTech Week 2025."Seth Zhang, Founder and CEO of MediTrust Health, stated that Artificial Intelligence (AI) i...
2025-11-06 14:53
1464
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 6, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific breakthro...
2025-11-06 14:11
1523
THE ADECCO GROUP Q3 2025 RESULTS
AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange Strong share gains, good growth and improved profit margin ZURICH, Nov. 6, 2025 /PRNewswire/ -- HIGHLIGHTS * Further strong market share gains, Group +375 bps and Adecco +300 bps * Group revenues +3.4% yoy, and +3...
2025-11-06 13:45
1095
Alphamab Oncology Showcases Cutting-edge Breakthroughs and Innovative Achievements at the 16th World ADC San Diego
SUZHOU, China, Nov. 6, 2025 /PRNewswire/ -- The 16th World ADC San Diego, held from November 3–6, 2025, brought together industry leaders inSan Diego, USA. Dr. Ting Xu, Founder, Chairman, and CEO of Alphamab Oncology, was invited to deliver a presentation titled "JSKN021: EGFR/HER3 Targeted Dual-...
2025-11-06 12:05
1783
The 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) will be held in Kunming, presenting a new landscape of integrated cancer prevention and treatment from a global perspective.
KUNMING, China, Nov. 5, 2025 /PRNewswire/ -- From November 6 to 9, 2025, the highly anticipated 2025 CCHIO will be grandly held in Kunming, the "Spring City". Hosted by the Chinese Anti-Cancer Association and the Secretariat of the Tengchong Scientists Forum Organizing Committee, co-hosted by the...
2025-11-06 10:58
1176
New Regional Certifications to Boost Healthcare Training Standards Across Southeast Asia
* Two new specially designed certification programmes will train doctors, nurses and technical specialists across the region in simulation-based medical education. SINGAPORE, Nov. 6, 2025 /PRNewswire/ -- The first healthcare simulation certification programmes designed specifically for Southeas...
2025-11-06 10:13
1208
The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia
Patient, Demonstrating Excellent Safety and Significant Efficacy
SHANGHAI, Nov. 6, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai,
China, CorrectSequence Therapeutics Co., Ltd. (Correctseq
2025-11-06 08:00
1394
Natural Field will Launch "Ashwagandha White Paper" at FTA Forum in Hangzhou
HANGZHOU, China, Nov. 5, 2025 /PRNewswire/ -- Natural Field, a leading Chinese supplier of botanical and functional ingredients, is set to release its highly anticipatedAshwagandha White Paper at the prestigious Food Technology and Application (FTA) Forum in Hangzhou. The forum, recognized as one...
2025-11-05 23:00
1196
Andor Health's Agentic AI Platform, ThinkAndor®, Receives Frost & Sullivan's 2025 North American Transformational Innovation Leadership Recognition for Excellence in Acute Care Virtual Health
Recognized for its transformational innovation and customer impact in driving
the evolution of acute care virtual health through advanced, agentic AI-powered
collaboration solutions.
SAN ANTONIO, Nov. 5, 2025 /PRNewswire/ -- Frost & Sullivan
2025-11-05 22:30
2407
Milliken & Company Recognized with 2025 EcoVadis Gold Rating, Placing in Top 5% Worldwide
SPARTANBURG, S.C., Nov. 5, 2025 /PRNewswire/ -- Milliken & Company, a global leader in manufacturing and material science, has earned a gold rating in the 2025 EcoVadis assessment for the fourth consecutive year, placing the company among the top 5% of more than 150,000 organizations evaluated ar...
2025-11-05 21:50
1362
BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC
* BioDlink helps Lepu Biopharma win China's marketing approval for EGFR-targeted ADC treating recurrent or metastatic nasopharyngeal carcinoma * This Becotatug Vedotin injection approval is BioDlink's first commercial ADC manufacturing initiative worldwide, validating its complex biologics co...
2025-11-05 21:00
1749
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025
* Showcased end-to-end, customized manufacturing capabilities covering vaccines, gene and immune therapeutics * Strengthening global CDMO strategy through strategic synergy with SK bioscience * Sustainable growth expected, backed by European commercial manufacturing infrastructure and regul...
2025-11-05 21:00
2109
Nona Biosciences Announces Expansion of Collaboration with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies
CAMBRIDGE, Mass., Nov. 5, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), today announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the clinical-stage leader of in vivo cell therapies that...
2025-11-05 20:07
1141
Week's Top Stories
Most Reposted
Visa partners with Laufey to spread the magic of travel in Asia Pacific; to be Official Payment Partner for Laufey: A Matter of Time Tour
[Picked up by 309 media titles]
2026-03-04 12:35
Klook's Spring Readiness Index shows how Asia's travelers are preparing for spring travel across Japan, South Korea, and Mainland China
[Picked up by 291 media titles]
2026-03-03 15:49
COL and NASDAQ-Listed BeLive Holdings Unveil World's First "Microdrama in a Box" in Headline Hong Kong FILMART 2026 Launch
[Picked up by 287 media titles]
2026-03-05 17:14
Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026
[Picked up by 267 media titles]
2026-03-04 10:00
The Ministry of Finance of Thailand, the Bank of Thailand, and the International Monetary Fund Underscore Significant Progress Toward the 2026 IMF-World Bank Group Annual Meetings
[Picked up by 266 media titles]
2026-03-05 12:18
